Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"N-acetylated alpha-linked acidic dipeptidase-like 1 pseudogene" (ENSG00000254655) is annotated in the genome as a pseudogene related to the enzyme NAALADL1. Pseudogenes lack the ability to produce functional protein and are generally not considered therapeutic targets. NAALADL1 itself is a protein-coding gene that encodes an aminopeptidase with broad substrate specificity, primarily involved in peptide catabolic processes. It is not a well-established drug target, nor is it commonly implicated in major disease mechanisms or therapeutic contexts. The term "N-acetylated alpha-linked acidic dipeptidase-like 1 pseudogene" is not a canonical, scientifically established target. The canonical form for the functional protein is "N-acetylated alpha-linked acidic dipeptidase like 1" (NAALADL1). ENSG00000254655 likely refers to a non-protein-coding locus; for structured knowledge bases, use NAALADL1 (ENSG00000168060) for any functional annotations or pharmacological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-acetylated alpha-linked acidic dipeptidase-like 1 pseudogene.